Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
TA-01
Cat. No.:
OB0225LY-0344
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
TA-01 is a potent inhibitor of CK1 and p38 MAPK.
CAS No.:
1784751-18-3
Formula:
C20H12F3N3
Formula Weight:
351.32
Specification
Relative Density:
1.337 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
TA-01 can be used in inflammation and immune response studies to help explore its role in relevant biological processes.
Library Information
Targets:
MAPK family; Casein kinase
Receptors:
Casein kinase; CK1δ; CK1ϵ; p38 MAPK
Pathways:
MAPK; Autophagy; Stem cells; Metabolism
Plate Number:
AOCL-5
Plate Location:
d8
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
9 mg/mL; 25.62 mM
